Maria Ines Mitrani is Chief Science Officer at Organicell Regenerative Medicine, Inc. (BPSR). They have made 13 open-market trades across 1 company since 2021, most recently 2021-10-29.
CIK 0001690319
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BPSR | 101,707,890 | — |
Shares reported on the most recent Form 4, priced at the 2021-11-02 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BPSR | SELL | 2021-06-17 | 2021-06-21 | $0.14 | $7K | N/A | N/A | N/A |
| BPSR | SELL | 2021-06-14 | 2021-06-16 | $0.15 | $23K | N/A | N/A | N/A |
| BPSR | SELL | 2021-06-09 | 2021-06-11 | $0.14 | $31K | N/A | N/A | N/A |
| BPSR | SELL | 2021-06-04 | 2021-06-08 | $0.13 | $34K | N/A | N/A | N/A |
| BPSR | SELL | 2021-06-01 | 2021-06-03 | $0.17 | $24K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-26 | 2021-05-28 | $0.18 | $26K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-21 | 2021-05-25 | $0.19 | $28K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-18 | 2021-05-20 | $0.20 | $41K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-13 | 2021-05-17 | $0.23 | $41K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-10 | 2021-05-12 | $0.29 | $51K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-05 | 2021-05-07 | $0.28 | $54K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-04 | 2021-05-05 | $0.41 | $21K | N/A | N/A | N/A |
| BPSR | SELL | 2021-04-30 | 2021-04-30 | $0.47 | $24K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.